Northeast Pharmaceutical Group Co Ltd (000597) — Free Cash Flow Generation Index
Northeast Pharmaceutical Group Co Ltd (000597) has a Free Cash Flow Generation Index of 0.96x as of September 2025. Free cash flow of CN¥262.61 Million represents 1% of operating cash flow (CN¥274.09 Million). Read Northeast Pharmaceutical Group Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Northeast Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (1999–2025)
Historical FCF Generation Index trend for Northeast Pharmaceutical Group Co Ltd across 23 annual periods. Explore 000597 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Northeast Pharmaceutical Group Co Ltd (1999–2025)
Year-by-year Free Cash Flow Generation Index for Northeast Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see 000597 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.91x | CN¥1.01 Billion | CN¥1.11 Billion | CN¥97.78 Million | ▲ +15.4% |
| 2024 | 0.79x | CN¥599.34 Million | CN¥758.76 Million | CN¥159.43 Million | ▲ +31.9% |
| 2023 | 0.60x | CN¥351.32 Million | CN¥586.75 Million | CN¥235.43 Million | ▼ -23.2% |
| 2022 | 0.78x | CN¥864.44 Million | CN¥1.11 Billion | CN¥244.13 Million | ▼ -7.1% |
| 2021 | 0.84x | CN¥626.70 Million | CN¥746.51 Million | CN¥119.81 Million | ▲ +181.0% |
| 2020 | 0.30x | CN¥170.54 Million | CN¥570.92 Million | CN¥400.38 Million | ▼ -14.7% |
| 2019 | 0.35x | CN¥123.43 Million | CN¥352.60 Million | CN¥229.17 Million | ▲ +135.6% |
| 2018 | -0.98x | CN¥-280.65 Million | CN¥285.09 Million | CN¥565.74 Million | ▼ -282.4% |
| 2016 | 0.54x | CN¥207.51 Million | CN¥384.51 Million | CN¥177.01 Million | ▲ +121.8% |
| 2015 | -2.47x | CN¥-246.34 Million | CN¥99.70 Million | CN¥346.04 Million | ▲ +76.1% |
| 2014 | -10.33x | CN¥-485.28 Million | CN¥46.99 Million | CN¥532.27 Million | ▼ -857.9% |
| 2012 | -1.08x | CN¥-92.81 Million | CN¥86.09 Million | CN¥178.90 Million | ▼ -26.6% |
| 2010 | -0.85x | CN¥-217.97 Million | CN¥255.96 Million | CN¥473.93 Million | ▼ -112.4% |
| 2009 | -0.40x | CN¥-246.88 Million | CN¥615.91 Million | CN¥862.78 Million | ▼ -181.3% |
| 2008 | 0.49x | CN¥349.76 Million | CN¥709.03 Million | CN¥359.27 Million | ▼ -11.6% |
| 2007 | 0.56x | CN¥110.78 Million | CN¥198.56 Million | CN¥87.78 Million | ▲ +702.3% |
| 2005 | 0.07x | CN¥7.75 Million | CN¥111.40 Million | CN¥103.66 Million | ▼ -90.2% |
| 2004 | 0.71x | CN¥149.92 Million | CN¥211.06 Million | CN¥61.14 Million | ▲ +14.6% |
| 2003 | 0.62x | CN¥142.63 Million | CN¥230.08 Million | CN¥87.46 Million | ▼ -18.2% |
| 2002 | 0.76x | CN¥119.34 Million | CN¥157.41 Million | CN¥38.07 Million | ▲ +85.2% |
| 2001 | 0.41x | CN¥32.27 Million | CN¥78.84 Million | CN¥46.57 Million | ▼ -38.2% |
| 2000 | 0.66x | CN¥23.94 Million | CN¥36.13 Million | CN¥12.18 Million | ▼ -19.9% |
| 1999 | 0.83x | CN¥45.22 Million | CN¥54.62 Million | CN¥9.41 Million | — |